GNPX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Genprex selected a leading contract development and manufacturing organization to scale up manufacturing of its diabetes gene therapyAug 18, 2026
- Genprex partnered with Roche Diagnostics on biomarker assay validation studiesAug 3, 2026
- Genprex announced that IP Australia intended to grant a patent for Reqorsa gene therapy combined with PD-L1 antibodies for cancer treatmentFeb 10, 2026
- Genprex reports positive preliminary preclinical data for GPX-002 in type 2 diabetes animal studiesJan 6, 2026
- Data from Genprex's Acclaim-1 Phase 1 gene therapy clinical trial was published in Clinical Lung CancerNov 24, 2025